FINDRISC (Finnish Diabetes Risk Score)

Why Use

Identifies individuals at risk for developing type 2 diabetes, guiding potential laboratory screenings (e.g., hemoglobin A1c) and enabling the implementation of preventive interventions. Recommended as a validated risk calculator by the Canadian Task Force on Preventive Health Care (CTFPHC).

When to Use

Used to assess a patient’s risk of type 2 diabetes during routine health maintenance visits.

Formula

Management

Suggested management based on the CTFPHC recommendations: Score Recommendation 0–14 points Routine screening for type 2 diabetes is not recommended. 15–20 points Hemoglobin A1c screening every 3–5 years. ≥21 points Hemoglobin A1c screening annually. For additional guidance on type 2 diabetes screening, please refer to the Canadian Task Force on Preventive Health Care guidelines .

Advice

This tool can be used to identify modifiable risk factors (e.g., diet, physical activity), which can be targeted through patient education and lifestyle modifications.

More Information

Interpretation: FINDRISC Risk 10-year risk of developing T2DM Men Women 0-3 Very low 0.3% 0.1% 4-8 Low 0.8% 0.4% 9-12 Moderate 2.6% 2.2% 13-20 High 23.1% 14.1% ≥ 21 Very high ~50%* ~50%* *From Lindström 2010 .